GMED
Globus Medical, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +12.5% ·
share flow -29.0% ·
net new positions +11.1%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 80.59K | $4.78M | n/a | n/a |
| Q2 2026 | 123 | -3 | 71.27M | $5.66B | +7 | −9 |
| Q1 2026 | 128 | +3 | 69.73M | $6.00B | +7 | −5 |
| Q4 2025 | 125 | -2 | 72.17M | $6.30B | +1 | −2 |
| Q3 2025 | 23 | +2 | 41.89M | $2.40B | +2 | −1 |
| Q2 2025 | 19 | -2 | 35.55M | $2.10B | n/a | −2 |
| Q1 2025 | 18 | +2 | 12.57M | $919.97M | +3 | −1 |
| Q4 2024 | 16 | 0 | 17.69M | $1.46B | +1 | −1 |
| Q3 2024 | 15 | 0 | 11.77M | $842.11M | +1 | −1 |
| Q2 2024 | 15 | n/a | 12.93M | $885.43M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 3.62M | +0.6% | $264.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.03M | +7.1% | $148.81M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 1.88M | -24.6% | $137.79M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 4 | T. Rowe Price ✦ | 1.15M | +2.2% | $84.06M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 1.13M | -20.5% | $82.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Marshall Wace ✦ | 833.15K | -26.7% | $60.99M | 0.1% | ▼ Trim | 4 | SEC ↗ ×3 |
| 7 | Capital World Investors ✦ | 574.50K | 0.0% | $42.05M | 0.0% | Held | 4 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 330.91K | -2.8% | $24.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 285.35K | -88.9% | $20.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 176.92K | New | $12.95M | 0.0% | New | 1 | SEC ↗ |
| 11 | GAMCO Investors ✦ | 133.81K | 0.0% | $9.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 133.11K | New | $9.74M | 0.0% | New | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 127.77K | +274.0% | $9.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 77.04K | New | $5.64M | 0.0% | New | 1 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 38.52K | -6.5% | $2.82M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 22.51K | +45.9% | $1.62M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 17 | Two Sigma Investments ✦ | 16.84K | -42.9% | $1.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Millennium Management ✦ | 13.65K | -99.2% | $998,960 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $12.95M | 0.0% |
| Bridgewater Associates | $9.74M | 0.0% |
| Arrowstreet Capital | $5.64M | 0.0% |
Exited
| Point72 Asset Management | $48.94M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 598 holders, 106.58M shares, $8.83B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 30.00K sh · $2.24M
Director · 25.00K sh · $2.18M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology